U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.40% to 34,850.49 while the NASDAQ fell 0.35% to 14,055.15. The S&P 500 also fell, dropping, 0.23% to 4,492.60.
By Chris Wack Homology Medicines shares were down 38% at 54 cents, a 52-week low, after the company received a buyout offer from Q32 Bio, a clinical stage.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 100 points on Thursday. The Dow traded down 0.39% to 34,853.42 while the NASDAQ fell 0.11% to 14,087.96. The S&P 500 also fell, dropping, 0.09% to 4,498.85.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Homology Medicines, Inc. and Q32 Bio Inc. is fair to Homology shareholders. Upon completion of the proposed.